The rationale for using hydroxycarbamide in the treatment of sickle cell disease.

The rationale for using hydroxycarbamide in the treatment of sickle cell disease.

Item
http://www.wikidata.org/entity/Q42708637
Haemoglobinopathies and the rheumatologistGeneration of a genomic reporter assay system for analysis of γ- and β-globin gene regulation.New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy.Management of sickle cell disease in the community.Emerging drugs for sickle cell anemia.Hydroxyurea therapy for sickle cell anemia.Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.Comment on "Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia".Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study.Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation.Hydroxyurea therapy in adult Nigerian sickle cell disease: a monocentric survey on pattern of use, clinical effects and patient's compliance.Nocturnal enuresis and K+ transport in red blood cells from patients with sickle cell anemia.The rationale for using hydroxycarbamide in the treatment of sickle cell disease" (Haematologica 2011;96:488-491). Reply.Effects of 5-hydroxymethyl-2-furfural on the volume and membrane permeability of red blood cells from patients with sickle cell disease.The effect of xanthine oxidase and hypoxanthine on the permeability of red cells from patients with sickle cell anemia.
P2860

The rationale for using hydroxycarbamide in the treatment of sickle cell disease.

Item
http://www.wikidata.org/entity/Q42708637
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
@en
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
@nl
type
label
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
@en
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
@nl
prefLabel
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
@en
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
@nl
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
The rationale for using hydroxycarbamide in the treatment of sickle cell disease.
@en
P2860
P304
P31
P356
10.3324/HAEMATOL.2011.041988
P433
P478
P50
P577
P5875
P698
P921
P932